The assessment of neurocognitive function and quality of life (QOL) in patients with brain metastases has become increasingly recognized as an important addition to traditional outcome measures such as length…
Leptomeningeal metastasis (LMD) is a lethal complication caused by a variety of cancers, typically developing late in the disease course. It is associated with major neurologic disabilities and short survival….
In the past 20 years, surgical resection has found an established role in the management of metastatic brain tumors. Several factors, however, make strong evidence-based medicine impossible to provide for…
Stereotactic radiosurgery (SRS) should be considered in the comprehensive treatment paradigm for all patients with brain metastases. This technique has proven benefits for local tumor control in individuals with as…
Skull base metastases (SBM) are rare among all tumors affecting the base of the skull. Because of their rarity, they have received limited attention in the published medical literature. Several…
Brain metastases affect 20% to 40% of patients with cancer and are the most common intracranial tumor in adults. The optimal treatment of brain metastases remains controversial. There are several…
Brain metastasis is one of the most common diagnoses encountered by neurologists, neurosurgeons, radiologists, and oncologists. The aim of this article is to review imaging modalities used in the diagnosis…
The main objective of treating brain metastases is to improve survival and to reduce symptom burden, preserve function, and enhance quality of life. As such, concurrent local control of existing…
As the length of survival continues to improve for patients with systemic cancers, the problem of metastases to the chemotherapeutic sanctuary of the central nervous system (CNS) continues to grow….
Metastatic tumors are the most common brain tumors in adults, and their incidence is increasing. An accurate understanding of the epidemiology of metastatic brain tumors is useful for health care…
